Drugs / Foundayo
Foundayo cost
orforglipron · Eli Lilly. Official self-pay prices by strength, what Medicare and savings offers cover, and the cost-related parts of the FDA label.
The short version
- Tablet: lowest listed self-pay price $149 per month (0.8 mg); highest regular price $299 per month.[1]
- The 2.5 mg price is temporarily $149 through Dec 31, 2026; the listed regular price is $199.[1]
- The 5.5 mg price is temporarily $199 through Dec 31, 2026; the listed regular price is $299.[1]
- For 14.5, 17.2 mg, the listed price applies to on-time refills; a refill more than 45 days after the last one costs $349.[1]
- Medicare GLP-1 Bridge: Foundayo is on the list of covered drugs. People who qualify pay $50 for a one-month supply.[2][3]
Foundayo Tablet: price by strength
Sold through LillyDirect (Eli Lilly self-pay). About this channel.
| Strength | Price per month | Conditions in the official listing | List price (WAC) |
|---|---|---|---|
| 0.8 mg | $149 | — | $649 |
| 2.5 mg | $149 | Temporary price through Dec 31, 2026. Regular price $199. | $649 |
| 5.5 mg | $199 | Temporary price through Dec 31, 2026. Regular price $299. | $649 |
| 9 mg | $299 | — | $649 |
| 14.5 mg | $299 | On-time refills. If a refill is more than 45 days after the last one: $349. | $649 |
| 17.2 mg | $299 | On-time refills. If a refill is more than 45 days after the last one: $349. | $649 |
“The price for the 2.5mg dose is temporarily reduced through December 31, 2026. Regular price is $199. The price for the 5.5mg dose is temporarily reduced through December 31, 2026. Regular price is $299. *Eligibility required, terms and conditions apply. Review full terms and conditions.”
Full offer terms: www.lilly.com/lillydirect/medicines/foundayo/foundayo-full-terms-conditions
Price history
Tracking began Oct 17, 2026. A new row appears only after a person has checked a change against the official page. All changes · Download CSV
| Checked | Form | Strengths | Lowest | Highest regular |
|---|---|---|---|---|
| 2026-10-17 | Tablet | 0.8, 2.5, 5.5, 9, 14.5, 17.2 mg | $149 | $299 |
From the FDA label
Word for word from the label on DailyMed: what the drug is approved for, the strengths and pack sizes (how many doses come in one carton or bottle), and the label's dose schedule.
FDA-approved uses · label 1
FOUNDAYOTM is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition.
Limitations of Use
Concomitant use with another GLP-1 receptor agonist is not recommended.
Dosage forms and strengths · label 3
FOUNDAYO tablets are available as orforglipron:
- 0.8 mg: pink round tablet debossed with “L” on one side and “G1” on the other side
- 2.5 mg: light yellow round tablet debossed with “L” on one side and “G2” on the other side
- 5.5 mg: grayish purple round tablet debossed with “L” on one side and “G3” on the other side
- 9 mg: pink modified oval tablet debossed with “Lilly” on one side and “G4” on the other side
- 14.5 mg: light yellow modified oval tablet debossed with “Lilly” on one side and “G5” on the other side
- 17.2 mg: grayish purple modified oval tablet debossed with “Lilly” on one side and “G6” on the other side
Dose schedule in the label · label 2.1
Recommended Administration
- Take FOUNDAYO orally once daily, with or without food.
- Swallow tablets whole. Do not break, crush, or chew.
- Do not take more than one tablet per day.
Recommended Dosage Escalation
Follow the FOUNDAYO starting dosage and escalation described below to reduce the risk of gastrointestinal (GI) adverse reactions [see Warnings and Precautions (5.3), Adverse Reactions (6)].
- The starting dosage is 0.8 mg orally once daily. After at least 30 days on the 0.8 mg dosage, increase the dosage to 2.5 mg once daily.
- After at least 30 days on the 2.5 mg dosage, increase the dosage to 5.5 mg once daily.
- The dosage may be increased to the next dosage level (9 mg, 14.5 mg, or 17.2 mg once daily) after at least 30 days on the current dosage, based on treatment response and tolerability.
- The maximum dosage of FOUNDAYO is 17.2 mg once daily.
How it is supplied (pack sizes) · label 16
16.1 How Supplied
FOUNDAYO (orforglipron) tablets are supplied in bottles with desiccant and child-resistant closure in cartons as follows:
| Tablet Strength of Orforglipron | Description | Package Configuration | NDC Number |
| 0.8 mg | Pink round tablet debossed with “L” on one side and “G1” on the other side | Bottles of 30 tablets | 0002-4178-31 |
| 2.5 mg | Light yellow round tablet debossed with “L” on one side and “G2” on the other side | Bottles of 30 tablets | 0002-4503-31 |
| 5.5 mg | Grayish purple round tablet debossed with “L” on one side and “G3” on the other side | Bottles of 30 tablets | 0002-4794-31 |
| 9 mg | Pink modified oval tablet debossed with “Lilly” on one side and “G4” on the other side | Bottles of 30 tablets | 0002-4803-31 |
| 14.5 mg | Light yellow modified oval tablet debossed with “Lilly” on one side and “G5” on the other side | Bottles of 30 tablets | 0002-4839-31 |
| 17.2 mg | Grayish purple modified oval tablet debossed with “Lilly” on one side and “G6” on the other side | Bottles of 30 tablets | 0002-4953-31 |
Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.
Official sources for this page
“The price for the 2.5mg dose is temporarily reduced through December 31, 2026. Regular price is $199. The price for the 5.5mg dose is temporarily reduced through December 31, 2026. Regular price is $299. *Eligibility required, terms and conditions apply. Review full terms and conditions.”
TrumpRx.gov: Foundayo Tablet listing · as of Oct 17, 2026“Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) Wegovy® (injection or tablet) Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens).”
Medicare.gov: Weight loss drugs · as of Oct 17, 2026“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
Medicare.gov: Weight loss drugs · as of Oct 17, 2026